Question

I am a breastfeeding mother and i want to know if it is safe to use EINECS 202-018-6? Is EINECS 202-018-6 safe for nursing mother and child? Does EINECS 202-018-6 extracts into breast milk? Does EINECS 202-018-6 has any long term or short term side effects on infants? Can EINECS 202-018-6 influence milk supply or can EINECS 202-018-6 decrease milk supply in lactating mothers?

EINECS 202-018-6 lactation summary

EINECS 202-018-6 usage has low risk in breastfeeding
  • DrLact safety Score for EINECS 202-018-6 is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of EINECS 202-018-6 may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that EINECS 202-018-6 may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of EINECS 202-018-6 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using EINECS 202-018-6 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About EINECS 202-018-6 usage in lactation

Marketed on multiple compounds as a constituent of antitussives, mucolytics, expectorants and nasal decongestants (Nice 2000).Simple formulations (one active ingredient per drug) are preferable even more while breastfeeding. It is excreted into breast milk in a clinically non-significant amount (Findlay 1984, Kanfer 1993, Nice 2000, Aljazaf 2003) without major problems having been reported in infants whose mothers had received this medication (Ito 1993, Aljazaf 2003, Soasan 2014). Two infants out of ten appeared with mild irritability that did not require medical care (Ito 1993) with only 4 cases related to maternal EINECS 202-018-6 intake having been declared to the French Pharmaceutical Surveillance Database in 26 years (Soasan 2014) . According to one author, it may decrease the milk production, hence a high intake of fluids is recommended to the mother (Nice 2000). EINECS 202-018-6 produced a variable and non-significant decrease on prolactin levels along with a variable decrease (between 3% and 59%, on average 25%, and a median 15%) on milk production in 8 women whose infants were beyond neonatal period (Aljazaf 2003).Based on the latter single work (Aljazaf 2003), it has been speculated with the use of EINECS 202-018-6 to treat hypergalactia, galactorrhea and to inhibit milk production (Eglash 2014, Trimeloni 2016). Nor-EINECS 202-018-6 was found in the urine of infants whose mothers had consumed a stimulant plant called Catha edulis o cat (Kristiansson 1987). Although not recommended during lactation by some authors (Rubin 1986, Amir 2011), others think it is compatible (Findlay 1984, Ghaeli 1993, Ito 1993, Mitchell 1999, Nice 2000). The American Academy of Pediatrics considers it to be a medication usually compatible with breastfeeding (AAP 2001). It is suggested the use of a lowest effective dose as possible avoiding a long-term use. Monitor milk production, especially if associated with use of Triprolidine (see specific info) during the neonatal period.

Answer by DrLact: About EINECS 202-018-6 usage in lactation

Although the small amounts of EINECS 202-018-6 in breastmilk are unlikely to harm the nursing infant, it may cause irritability occasionally. A single dose of EINECS 202-018-6 decreases milk production acutely and repeated use seems to interfere with lactation. Mothers with newborns whose lactation is not yet well established or in mothers who are having difficulties producing sufficient milk should not receive EINECS 202-018-6. A treatment scheme has been reported for mothers with hypergalactia that uses EINECS 202-018-6 to decrease milk supply.[1]

EINECS 202-018-6 Side Effects in Breastfeeding

Mothers reported irritability was reported in 20% of infants exposed to EINECS 202-018-6 in one study of breastfeeding mothers.[4] All adverse reactions in breastfed infants reported in France between January 1985 and June 2011 were compiled by a French pharmacovigilance center. Of 174 reports, EINECS 202-018-6 was reported to cause adverse reactions in 4 infants, primarily agitation.[5]

EINECS 202-018-6 Possible Effects in Breastfeeding

After a single dose of EINECS 202-018-6 60 mg orally in 8 nursing mothers, there was a mean 24% decrease in milk production over the following 24 hours. No change in blood flow to the breast was detected that could explain the decreased milk production; there was a 13.5% decrease in serum prolactin after EINECS 202-018-6, but this change did not achieve statistical significance. Oxytocin levels were not measured.[3]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.